
A trial run in Devon by PRC: Exeter has given hope of adding another effective vaccine to the UK’s armoury against COVID
29 January 2021
The NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, shown from interim analysis of its Phase III study data, including effectiveness against the new variants of concern.